為達最佳瀏覽效果,建議使用 Chrome、Firefox 或 Microsoft Edge 的瀏覽器。

請至Edge官網下載 請至FireFox官網下載 請至Google官網下載
晴時多雲

限制級
您即將進入之新聞內容 需滿18歲 方可瀏覽。
根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw

《TAIPEI TIMES》 Airport voluntary illness screenings start


People walk through Taipei International Airport (Songshan airport) on Sept. 28.
Photo: CNA

People walk through Taipei International Airport (Songshan airport) on Sept. 28. Photo: CNA

2023/12/01 03:00

ARRIVALS FROM CHINA: No new cases of ‘M. pneumonia’ infection were reported by the voluntary screenings of passengers from China arriving at international airports

By Chung Li-huaand Jonathan Chin / Staff reporter, with staff writer

Voluntary screenings for respiratory illnesses for people traveling from China, including Hong Kong and Macau, have begun in response to a surge of pneumonic diseases, the Centers for Disease Control (CDC) said yesterday.

The measures enacted on Sunday were part of an effort to monitor seven types of concerning pneumonic diseases surging in China, including Mycoplasma pneumoniae infections, influenza and COVID-19, CDC Deputy Director-General Philip Lo (羅一鈞) told a news conference at the Executive Yuan in Taipei.

No new cases of M. pneumonia infection were reported by the voluntary screenings of passengers from China arriving at the international airports in Taipei, Taoyuan, Taichung and Kaohsiung, he said.

The global respiratory disease season appears to have arrived early this year and the M. pneumoniae bacteria are expected to spread, but no new pathogen has been detected, he said, citing the WHO.

M. pneumonia infection poses a heightened risk to children, while COVID-19 remains a danger to adults, Lo said.

Meanwhile, domestic monitoring showed that community spread of respiratory diseases is declining, with the most common types of infection being influenza, adenovirus and parainfluenza, he said.

Communal cases of COVID-19 and emergency department visits for M. pneumoniae infection are “in flux,” he said, adding that data from one medical center suggest that the latter illness accounted for less than 1 percent of all respiratory cases.

Taiwan has enough medicine to treat M. pneumoniae cases in children following increased imports beginning last month, while a generic version of the drug is scheduled for domestic mass production beginning this month, he said.

Separately, Chinese Nationalist Party (KMT) Legislator Lin Wei-chou (林為洲) said that more should be done to bolster a reported insufficient supply of drugs to treat the disease, including antibiotics and fever medicines to handle a potential pandemic.

Doctors reporting to the lawmaker’s office said that they cannot obtain any imported antibiotics, while domestically produced ones are being rationed, Lin told a news conference at the Legislative Yuan in Taipei.

The Food and Drug Administration should set up a hotline for hospitals to request direct shipments of antibiotics as it would other medical supplies during an emergency, he said.

Clinics and hospitals have had difficulty acquiring fever syrup to treat M. pneumoniae cases in children for the past two months, pharmacist Shen Tsai-ying (沈采穎) said.

The government’s medicine platform is not useful for medical practitioners, as information about generic substitutes has not increased supplies, Shen said.

The unavailability of fever syrups could endanger children under six months should the pneumonia situation worsen, she said.

新聞來源:TAIPEI TIMES

不用抽 不用搶 現在用APP看新聞 保證天天中獎  點我下載APP  按我看活動辦法

焦點今日熱門

2024巴黎奧運

看更多!請加入自由時報粉絲團

網友回應

載入中
此網頁已閒置超過5分鐘,請點擊透明黑底或右下角 X 鈕。